| scholarly article | Q13442814 |
| P50 | author | Karine Clément | Q62104165 |
| Michèle Guerre-Millo | Q124091208 | ||
| P2093 | author name string | Jie Zhang | |
| Jian Liu | |||
| Min Yang | |||
| Guo-Ping Shi | |||
| Bruce D Gelb | |||
| Jiusong Sun | |||
| Froogh Darakhshan | |||
| Tinghu Zhang | |||
| Michael A Shi | |||
| Gregory Dolgnov | |||
| P2860 | cites work | Identification of a novel gene encoding an insulin-responsive glucose transporter protein | Q24338976 |
| Obesity is associated with macrophage accumulation in adipose tissue | Q27860976 | ||
| Endosomal proteolysis of internalized insulin at the C-terminal region of the B chain by cathepsin D | Q28214776 | ||
| Insulin degradation: progress and potential | Q28287093 | ||
| Obesity induces a phenotypic switch in adipose tissue macrophage polarization | Q29547686 | ||
| Defects in mesoderm, neural tube and vascular development in mouse embryos lacking fibronectin | Q29617865 | ||
| Inhibition of cathepsin K with lysosomotropic macromolecular inhibitors | Q30702065 | ||
| Cathepsin K in adipocyte differentiation and its potential role in the pathogenesis of obesity | Q33254108 | ||
| Cathepsin L activity controls adipogenesis and glucose tolerance | Q34654358 | ||
| Deficiency of cathepsin S reduces atherosclerosis in LDL receptor-deficient mice | Q34967612 | ||
| Review article: adipocytokines and insulin resistance | Q36286269 | ||
| Degradation of mouse invariant chain: roles of cathepsins S and D and the influence of major histocompatibility complex polymorphism | Q36380525 | ||
| Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice | Q36791739 | ||
| Identification of cathepsin K as a novel marker of adiposity in white adipose tissue. | Q40661967 | ||
| Fibronectin modulation of cell shape and lipogenic gene expression in 3T3-adipocytes | Q42820082 | ||
| Insulin resistance is mediated by a proteolytic fragment of the insulin receptor | Q42823390 | ||
| Arylaminoethyl amides as novel non-covalent cathepsin K inhibitors | Q44010036 | ||
| Weight loss reduces adipose tissue cathepsin S and its circulating levels in morbidly obese women | Q46880197 | ||
| Cathepsin K in thyroid epithelial cells: sequence, localization and possible function in extracellular proteolysis of thyroglobulin. | Q47813796 | ||
| Cathepsin s promotes human preadipocyte differentiation: possible involvement of fibronectin degradation | Q50335753 | ||
| Extracellular matrix substrata alter adipocyte yield and lipogenesis in primary cultures of stromal-vascular cells from human adipose. | Q51722962 | ||
| Comprehensive transcriptome of proteases and protease inhibitors in vascular cells. | Q54625618 | ||
| Cathepsin S, a novel biomarker of adiposity: relevance to atherogenesis | Q57420159 | ||
| Defects in insulin-receptor internalization and processing in monocytes of obese subjects and obese NIDDM patients | Q69554764 | ||
| Dose-response curves for in vivo insulin sensitivity in individual tissues in rats | Q69885313 | ||
| Thyroid hormone metabolism in obesity | Q74345589 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | glucose | Q37525 |
| glycobiology | Q899224 | ||
| weight gain | Q3403879 | ||
| P304 | page(s) | 2202-2208 | |
| P577 | publication date | 2008-09-25 | |
| P1433 | published in | Arteriosclerosis, Thrombosis, and Vascular Biology | Q4797542 |
| P1476 | title | Deficiency and inhibition of cathepsin K reduce body weight gain and increase glucose metabolism in mice | |
| P478 | volume | 28 |
| Q35605294 | Adipose tissue remodeling in pathophysiology of obesity |
| Q51320695 | An allosteric site enables fine-tuning of cathepsin K by diverse effectors. |
| Q48348409 | Cathepsin K Deficiency Ameliorates Systemic Lupus Erythematosus-like Manifestations in Faslpr Mice. |
| Q33973023 | Cathepsin K deficiency in mice induces structural and metabolic changes in the central nervous system that are associated with learning and memory deficits |
| Q35527162 | Cathepsin K knockout alleviates aging-induced cardiac dysfunction |
| Q37593416 | Cathepsin K knockout alleviates pressure overload-induced cardiac hypertrophy |
| Q36560578 | Cathepsin K knockout mitigates high-fat diet-induced cardiac hypertrophy and contractile dysfunction |
| Q41458755 | Cathepsin K knockout protects against cardiac dysfunction in diabetic mice |
| Q38784335 | Cathepsin K osteoporosis trials, pycnodysostosis and mouse deficiency models: Commonalities and differences |
| Q37889119 | Cathepsin K: its skeletal actions and role as a therapeutic target in osteoporosis |
| Q35851900 | Cathepsin L activity is essential to elastase perfusion-induced abdominal aortic aneurysms in mice |
| Q51719566 | Cathepsin S inhibition lowers blood glucose levels in mice. |
| Q57696081 | Clusterin is a specific stabilizer and liberator of extracellular cathepsin K |
| Q90648216 | Comparison of salivary proteome of children with different sensitivities for bitter and sweet tastes: association with body mass index |
| Q43070071 | Conformational flexibility and allosteric regulation of cathepsin K. |
| Q35098737 | Cysteinyl cathepsins and mast cell proteases in the pathogenesis and therapeutics of cardiovascular diseases |
| Q36211889 | Cysteinyl cathepsins: multifunctional enzymes in cardiovascular disease |
| Q28728934 | Dietary factors impact on the association between CTSS variants and obesity related traits |
| Q92846993 | Differential Roles of Cysteinyl Cathepsins in TGF-β Signaling and Tissue Fibrosis |
| Q42175266 | Effects of cathepsin K deficiency on intercellular junction proteins, luminal mucus layers, and extracellular matrix constituents in the mouse colon |
| Q26825467 | Emerging role of mast cells and macrophages in cardiovascular and metabolic diseases |
| Q39385660 | Engineered nanomaterial-induced lysosomal membrane permeabilization and anti-cathepsin agents |
| Q53593111 | High-fat diet decreases energy expenditure and expression of genes controlling lipid metabolism, mitochondrial function and skeletal system development in the adipose tissue, along with increased expression of extracellular matrix remodelling- and i |
| Q51795887 | Human cathepsin L, a papain-like collagenase without proline specificity. |
| Q34110586 | Immunoglobulin E and mast cell proteases are potential risk factors of human pre-diabetes and diabetes mellitus |
| Q48588869 | Impact of circulating cathepsin K on the coronary calcification and the clinical outcome in chronic kidney disease patients |
| Q37933395 | Inhibitors of cathepsin K: a patent review (2004 - 2010). |
| Q53589878 | Low-dose diet supplement of a natural flavonoid, luteolin, ameliorates diet-induced obesity and insulin resistance in mice. |
| Q38195943 | Lysosomal cholesterol accumulation: driver on the road to inflammation during atherosclerosis and non-alcoholic steatohepatitis |
| Q37578873 | Mast cell chymase and tryptase as targets for cardiovascular and metabolic diseases |
| Q35868633 | Mast cell stabilization: novel medication for obesity and diabetes |
| Q28072006 | Molecular Mechanisms of Obesity-Induced Osteoporosis and Muscle Atrophy |
| Q36068555 | Obesity-induced remodeling of the adipose tissue elastin network is independent of the metalloelastase MMP-12. |
| Q34476390 | Proteases in cardiometabolic diseases: Pathophysiology, molecular mechanisms and clinical applications |
| Q37797839 | Specialized roles for cysteine cathepsins in health and disease. |
| Q56965694 | Thyroid Cathepsin K: Roles in Physiology and Thyroid Disease |
| Q92686596 | Whole-exome sequencing identified a novel variant in an Iranian patient affected by pycnodysostosis |
Search more.